Sonoma Pharmaceuticals (SNOA) Depreciation & Amortization (CF) (2010 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Depreciation & Amortization (CF) of $33000.0 for Q1 2026, up 6.45% year-over-year from $31000.0 in Q1 2025, and down 2.94% quarter-over-quarter from $34000.0 in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $33000.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) rose 6.45% year-over-year to $33000.0; the TTM figure through Mar 2026 stood at $139000.0 (up 0.72% YoY), while the FY2026 annual figure was $139000.0, up 0.72% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $33000.0, down from $34000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $49000.0 in Q1 2022, with the low at $28000.0 in Q3 2022.
- The 5-year median for Depreciation & Amortization (CF) is $35000.0 (2024), against an average of $36882.4.
- The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) slumped 46.15% in 2022, then jumped 60.71% in 2023.
- Sonoma Pharmaceuticals' Depreciation & Amortization (CF) stood at $32000.0 in 2022, then soared by 40.62% to $45000.0 in 2023, then fell by 26.67% to $33000.0 in 2024, then gained by 3.03% to $34000.0 in 2025, then slipped by 2.94% to $33000.0 in 2026.
- Business Quant data shows SNOA's Depreciation & Amortization (CF) at $33000.0 in Q1 2026, $34000.0 in Q4 2025, and $36000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn | 32,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32,000.00 |
| Jun 30, 2026 | 32,000.00 |
| Mar 31, 2026 | 33,000.00 |
| Mar 31, 2026 | 33,000.00 |
| Dec 31, 2025 | 34,000.00 |
| Dec 31, 2025 | 34,000.00 |
| Sep 30, 2025 | 36,000.00 |
| Sep 30, 2025 | 36,000.00 |
| Jun 30, 2025 | 36,000.00 |
| Jun 30, 2025 | 36,000.00 |
| Mar 31, 2025 | 31,000.00 |
| Mar 31, 2025 | 31,000.00 |
| Dec 31, 2024 | 33,000.00 |
| Dec 31, 2024 | 33,000.00 |
| Sep 30, 2024 | 35,000.00 |
| Sep 30, 2024 | 35,000.00 |
| Jun 30, 2024 | 39,000.00 |
| Jun 30, 2024 | 39,000.00 |
| Mar 31, 2024 | 41,000.00 |
| Mar 31, 2024 | 41,000.00 |